Tag: Kyprolis

Natco Pharma gets FDA approval for Carfilzomib Vials ANDA

businessnewstoday- June 20, 2021 0

Natco Pharma Limited said that its marketing partner - Breckenridge Pharmaceutical Inc. (BPI), has secured approval from the US Food and Drug Administration (FSA) for ... Read More

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

pharmanewsdaily- August 23, 2020 0

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the ... Read More

Amgen to take 20.5% stake in Chinese biotech company BeiGene for $2.7bn

pharmanewsdaily- November 5, 2019 0

US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per ... Read More

CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients

pharmanewsdaily- September 13, 2019 0

CANDOR clinical trial results : Amgen said that a phase 3 study assessing Kyprolis (carfilzomib) in combination with dexamethasone and Johnson & Johnson's Darzalex (daratumumab) ... Read More

FDA approves new dosing option for Amgen blood cancer drug Kyprolis

pharmanewsdaily- October 2, 2018 0

The US Food and Drug Administration (FDA) has approved a weekly once dosing option for Amgen blood cancer drug Kyprolis (carfilzomib) in combination with dexamethasone ... Read More